These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

377 related items for PubMed ID: 18430084

  • 1. A novel autotransporter of uropathogenic Proteus mirabilis is both a cytotoxin and an agglutinin.
    Alamuri P, Mobley HL.
    Mol Microbiol; 2008 May; 68(4):997-1017. PubMed ID: 18430084
    [Abstract] [Full Text] [Related]

  • 2. Vaccination with proteus toxic agglutinin, a hemolysin-independent cytotoxin in vivo, protects against Proteus mirabilis urinary tract infection.
    Alamuri P, Eaton KA, Himpsl SD, Smith SN, Mobley HL.
    Infect Immun; 2009 Feb; 77(2):632-41. PubMed ID: 19029299
    [Abstract] [Full Text] [Related]

  • 3. Identification of protease and rpoN-associated genes of uropathogenic Proteus mirabilis by negative selection in a mouse model of ascending urinary tract infection.
    Zhao H, Li X, Johnson DE, Mobley HLT.
    Microbiology (Reading); 1999 Jan; 145 ( Pt 1)():185-195. PubMed ID: 10206698
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Use of green fluorescent protein to assess urease gene expression by uropathogenic Proteus mirabilis during experimental ascending urinary tract infection.
    Zhao H, Thompson RB, Lockatell V, Johnson DE, Mobley HL.
    Infect Immun; 1998 Jan; 66(1):330-5. PubMed ID: 9423875
    [Abstract] [Full Text] [Related]

  • 7. Proteus mirabilis uroepithelial cell adhesin (UCA) fimbria plays a role in the colonization of the urinary tract.
    Pellegrino R, Scavone P, Umpiérrez A, Maskell DJ, Zunino P.
    Pathog Dis; 2013 Mar; 67(2):104-7. PubMed ID: 23620155
    [Abstract] [Full Text] [Related]

  • 8. Flagellate and non-flagellate Proteus mirabilis in the development of experimental urinary tract infection.
    Zunino P, Piccini C, Legnani-Fajardo C.
    Microb Pathog; 1994 May; 16(5):379-85. PubMed ID: 7815921
    [Abstract] [Full Text] [Related]

  • 9. The type III secretion system of Proteus mirabilis HI4320 does not contribute to virulence in the mouse model of ascending urinary tract infection.
    Pearson MM, Mobley HLT.
    J Med Microbiol; 2007 Oct; 56(Pt 10):1277-1283. PubMed ID: 17893161
    [Abstract] [Full Text] [Related]

  • 10. Preventive and therapeutic administration of an indigenous Lactobacillus sp. strain against Proteus mirabilis ascending urinary tract infection in a mouse model.
    Fraga M, Scavone P, Zunino P.
    Antonie Van Leeuwenhoek; 2005 Jul; 88(1):25-34. PubMed ID: 15928974
    [Abstract] [Full Text] [Related]

  • 11. Pathogenesis of Proteus mirabilis Infection.
    Armbruster CE, Mobley HLT, Pearson MM.
    EcoSal Plus; 2018 Feb; 8(1):. PubMed ID: 29424333
    [Abstract] [Full Text] [Related]

  • 12. UreR, the transcriptional activator of the Proteus mirabilis urease gene cluster, is required for urease activity and virulence in experimental urinary tract infections.
    Dattelbaum JD, Lockatell CV, Johnson DE, Mobley HL.
    Infect Immun; 2003 Feb; 71(2):1026-30. PubMed ID: 12540589
    [Abstract] [Full Text] [Related]

  • 13. Involvement of polyphosphate kinase in virulence and stress tolerance of uropathogenic Proteus mirabilis.
    Peng L, Jiang Q, Pan JY, Deng C, Yu JY, Wu XM, Huang SH, Deng XY.
    Med Microbiol Immunol; 2016 Apr; 205(2):97-109. PubMed ID: 26233310
    [Abstract] [Full Text] [Related]

  • 14. Requirement of MrpH for mannose-resistant Proteus-like fimbria-mediated hemagglutination by Proteus mirabilis.
    Li X, Johnson DE, Mobley HL.
    Infect Immun; 1999 Jun; 67(6):2822-33. PubMed ID: 10338487
    [Abstract] [Full Text] [Related]

  • 15. Complete genome sequence of uropathogenic Proteus mirabilis, a master of both adherence and motility.
    Pearson MM, Sebaihia M, Churcher C, Quail MA, Seshasayee AS, Luscombe NM, Abdellah Z, Arrosmith C, Atkin B, Chillingworth T, Hauser H, Jagels K, Moule S, Mungall K, Norbertczak H, Rabbinowitsch E, Walker D, Whithead S, Thomson NR, Rather PN, Parkhill J, Mobley HL.
    J Bacteriol; 2008 Jun; 190(11):4027-37. PubMed ID: 18375554
    [Abstract] [Full Text] [Related]

  • 16. New aspects of RpoE in uropathogenic Proteus mirabilis.
    Liu MC, Kuo KT, Chien HF, Tsai YL, Liaw SJ.
    Infect Immun; 2015 Mar; 83(3):966-77. PubMed ID: 25547796
    [Abstract] [Full Text] [Related]

  • 17. MrpJ Directly Regulates Proteus mirabilis Virulence Factors, Including Fimbriae and Type VI Secretion, during Urinary Tract Infection.
    Debnath I, Stringer AM, Smith SN, Bae E, Mobley HLT, Wade JT, Pearson MM.
    Infect Immun; 2018 Oct; 86(10):. PubMed ID: 30082479
    [Abstract] [Full Text] [Related]

  • 18. The high-affinity phosphate transporter Pst is a virulence factor for Proteus mirabilis during complicated urinary tract infection.
    Jacobsen SM, Lane MC, Harro JM, Shirtliff ME, Mobley HL.
    FEMS Immunol Med Microbiol; 2008 Mar; 52(2):180-93. PubMed ID: 18194341
    [Abstract] [Full Text] [Related]

  • 19. Mannose-resistant Proteus-like and P. mirabilis fimbriae have specific and additive roles in P. mirabilis urinary tract infections.
    Zunino P, Sosa V, Schlapp G, Allen AG, Preston A, Maskell DJ.
    FEMS Immunol Med Microbiol; 2007 Oct; 51(1):125-33. PubMed ID: 17854474
    [Abstract] [Full Text] [Related]

  • 20. Repression of bacterial motility by a novel fimbrial gene product.
    Li X, Rasko DA, Lockatell CV, Johnson DE, Mobley HL.
    EMBO J; 2001 Sep 03; 20(17):4854-62. PubMed ID: 11532949
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.